Official ESCRS | European Society of Cataract & Refractive Surgeons
London 2014 Registration Visa Letters Programme Satellite Meetings Glaucoma Day 2014 Exhibition Hotel Booking Virtual Exhibition Star Alliance
london escrs

Course handouts are now available
Click here


Come to London

video-icon

WATCH to find out why


Site updates:

Programme Updates. Programme Overview and - Video Symposium on Challenging Cases now available.


Posters

Search Abstracts by author or title
(results will display both Free Papers & Poster)

Simultaneous photorefractive keratectomy and collagen cross-linking in patients with an increased risk for post-refractive surgery corneal ectasia

Poster Details

First Author: O.Ohana ISRAEL

Co Author(s):    Y. Domnitz   G. Munzer   E. Cohen   D. Varssano     

Abstract Details



Purpose:

To report the surgical outcomes and complication profile in patients with an increased surgical risk for post-photorefractive keratectomy (PRK) ectasia undergoing simultaneous PRK and collagen crosslinking (CXL).

Setting:

Care laser, Tel-Aviv, Israel. A private refractive surgery clinic.

Methods:

A Retrospective interventional case series.Patients classified as having high-risk for post-refractive surgery corneal ectasia by the surgeon were included. Patients were treated with PRK immediately followed by CXL with UV/riboflavin (PRK-CXL). Main outcomes were safety, uncorrected distance visual acuity (UDVA), spherical equivalent (SE), refractive-, keratometric- and pachymetric- stability and the occurrence of postoperative complications such as haze and corneal ectasia.

Results:

The study evaluated 136 eyes of 77 patients treated with PRK-CXL. Mean age was 27.69 ± 6.6 years. Mean Follow-up was 367.16 ± 196.5 days (range 96-778). Pre-operative UDVA was 1.38 ± 0.61 LogMAR and improved significantly to 0.13 ± 0.21 LogMAR at the last follow up (P<0.001). Best-corrected visual acuity was 0.06 ± 0.09 LogMAR pre-operatively, which remained stable post-operatively at 0.07 ± 0.10 LogMAR, not a statistically significant difference (P = 0.28). Pre-operative mean SE was 4.49 ± 2.81 Diopter (D), which was significantly reduced to -0.02 ± 1.01 D (P<0.001). Pre-operative Central Corneal Thickness (CCT) was 495.52 ± 40.85 micron and was significantly reduced to 371.48 ± 47.56 micron post-operatively (P<0.001). CCT remained stable throughout follow up. At the last follow up 69.9% of the patients were within ±0.50D from emmetropia and 88.2% were within ±1.00D from emmetropia. Four eyes had significant corneal haze (grades 3 and 4). No corneal ectsia cases were seen during follow up.

Conclusions:

PRK-CXL in eyes with increased risk for developing post-refractive ectasia but without keratoconus seems to be a safe and effective procedure, providing predictable, stable, refractive results. Haze is a clinically significant complication. FINANCIAL INTEREST: NONE

Back to Poster listing